Sutro Biopharma, Inc.
NASDAQ:STROBiotechnology
Healthcare
$8.72 +1.13%
+$0.32 today
- Market cap
- $144.76M
- Beta
- 1.55
- P/E (TTM)
- -0.0
- EPS (TTM)
- -$1,174.12
52W Low $6.70High $43.85
Volume 0.24M
Average 0.28M
Balance Sheet
Inspect the capital base behind the business.
Assets
$173.83M
FY 2025 · Annual
-55.1% YoYLiabilities
$306.28M
FY 2025 · Annual
-10.6% YoYEquity
-$132.45M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 30.41M | 47.25M | 69.27M | 190.3M | 58.13M |
| Short-term Investments | 167.52M | 287.11M | 306.35M | 126.59M | 83.3M |
| Net Receivables | 12.45M | 7.12M | 36.08M | 8.62M | 3.98M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1 | 11.67M | 9.85M | 17.8M | 5.52M |
| Total Current Assets | 218.52M | 353.15M | 421.54M | 343.31M | 150.93M |
| Property, Plant & Equipment (Net) | 51.59M | 51.06M | 44.76M | 35.87M | 21.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 68.78M | (32.02M) | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.53M | 34.75M | 4.44M | 8.03M | 1.35M |
| Total Non-current Assets | 122.89M | 53.79M | 49.19M | 43.9M | 22.9M |
| Total Assets | 341.41M | 406.94M | 470.74M | 387.21M | 173.83M |
| Account Payables | 6.01M | 4.8M | 9.44M | 10.48M | 7.57M |
| Short-term Debt | 9.38M | 17.09M | 4.06M | 0 | 0 |
| Tax Payables | 0 | 0 | 15.17M | 18K | 0 |
| Deferred Revenue | 5.5M | 16.76M | 20.67M | 69.78M | 10.56M |
| Other Current Liabilities | 11.42M | 11.64M | 18.58M | 16.91M | 17.56M |
| Total Current Liabilities | 41.74M | 66.55M | 93.75M | 131.89M | 75.13M |
| Long-term Debt | 15.74M | 3.77M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 89.89M | 202.49M | 193.35M | 221.56M |
| Other Non-current Liabilities | 146K | 119K | 1.69M | 1.69M | 1.69M |
| Total Non-current Liabilities | 47.11M | 123.35M | 227.34M | 210.71M | 231.15M |
| Total Liabilities | 88.84M | 189.9M | 321.09M | 342.61M | 306.28M |
| Common Stock | 46K | 58K | 61K | 83K | 9K |
| Retained Earnings | (333.41M) | (452.62M) | (559.41M) | (786.87M) | (977.96M) |
| Accumulated OCI | (314K) | (618K) | 21K | 39K | 19K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 252.56M | 217.05M | 149.65M | 44.6M | (132.45M) |
| Total Debt | 57.37M | 55.02M | 33.64M | 23.15M | 15.67M |
| Net Debt | 26.96M | 7.76M | (35.63M) | (167.15M) | (42.46M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $73.7M |
| Short-term Investments | $128.9M |
| Receivables | $12.5M |
| Other Current | $5.9M |
| Total Current Assets | $221.0M |
| PP&E (Net) | $19.1M |
| Other Non-current | $1.9M |
| Total Non-current Assets | $21.0M |
| Total Assets | $242.0M |
Analysis
Selected assets total $242.0M for Latest. The largest visible component is Short-term Investments at $128.9M, about 53.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| SC 13G | SC 13G filing | Nov 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 22, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 |
How much cash does STRO have?
Sutro Biopharma, Inc. (STRO) reported $58.13M in cash and equivalents in fiscal 2025.
How much debt does STRO carry?
Sutro Biopharma, Inc. (STRO) reported $15.67M of total debt, with net debt of -$42.46M.
Continue the stock analysis
Jump to another research area for this company.